NERV SCHEDULE 13G/A: SEC filing
Coastlands Capital LP and affiliated reporting persons
Filed with the SEC on · accession 0001104659-26-127420
NERV filed a SCHEDULE 13G/A (schedule 13g/a) with the SEC on Nov 13, 2026. A report the company filed with the SEC (the US market regulator). The stock moved -3.4% by the first close after the filing.
Summary of the filing
Coastlands Capital LP and affiliated reporting persons filed Amendment No. 1 to Schedule 13G disclosing beneficial ownership of 5,052,055 shares of Minerva Neurosciences common stock, representing 9.99% of the class, reflecting transactions in the common stock.
Key details
How NERV stock reacted
Close before
$2.38
Nov 12, 2026
First close after
-3.36%
$2.30
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for NERV, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for NERV?
Click hereFrequently asked questions
What did NERV file with the SEC on Nov 13, 2026?
NERV filed a SCHEDULE 13G/A (SEC filing). Coastlands Capital LP and affiliated reporting persons filed Amendment No. 1 to Schedule 13G disclosing beneficial ownership of 5,052,055 shares of Minerva Neurosciences common stock, representing 9.99% of the class, reflecting transactions in the common stock.
How do I read a SCHEDULE 13G/A?
A report the company filed with the SEC (the US market regulator). Start with the summary, then the key amounts and names. Compare it with the company’s earlier filings.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A SCHEDULE 13G/A (schedule 13g/a): A report the company filed with the SEC (the US market regulator).
How did NERV stock react to this filing?
NERV closed at $2.38 before the filing and $2.30 on Nov 13, 2026 (-3.36%).
Other NERV SEC filings
Get alerts when NERV files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days